The agonist of dopamine receptors piribedil in treatment of Parkinson’s disease-Reference-Cited by-同舟云学术

The agonist of dopamine receptors piribedil in treatment of Parkinson’s disease

Published:2017 Issue:6 Volume:117 Page:83
ISSN:1997-7298
Container-title:Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
language:en
Short-container-title:Z. nevrol. psikhiatr. im. S.S. Korsakova

Author:

Pilipovich A. A.,Golubev V. L.

Publisher

Media Sphere Publishing Group

Subject

Psychiatry and Mental health,Neurology (clinical)

Reference62 articles.

1. National Institute for Health and Clinical Excellence. Parkinson’s disease: diagnosis and management in primary and secondary care (Internet). London: The Institute; 2006. (cited 2013 Oct 1). (NICE clinical guideline 35). Available from: http://www.nice.org.uk/nicemedia/pdf/cg035niceguideline.pdf. (Referencelist).

2. Ekstrapiramidnyerasstroistvavchera, segodnya, zavtra. Sb. st. Podred. Levina O.S. 2-e izd. М. 2015. (In Russ.)

3. Gene Therapy: A Promising Approach for Neuroprotection in Parkinson’s Disease?

4. Neuroimmunophilin ligands in the treatment of Parkinson's disease

5. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Motor and autonomic disorders influence on pain syndrome of patients with Parkinson’s disease of the I—III H&Y stages;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

2. Mild Cognitive Impairment: Current Aspects of Diagnosis and Treatment;Neuroscience and Behavioral Physiology;2021-10

3. Mild cognitive impairment: modern aspects of diagnostics and therapy;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2020

4. Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis;Cancer Letters;2018-09